GL1X · GenesisL1 explorer

MolNFT v1 · #166006 · protein

Co-crystal structure of compound 1 bound to human mcl-1

6UD2 · Induced myeloid leukemia cell differentiation protein mcl- 1: “Co-crystal structure of compound 1 bound to human mcl-1”. X-ray diffraction, 1 ligand (Q4D), 1 pocket (best druggability 0.60). MolNFT v1 #166006 on GenesisL1: 3D…

PDB
6UD2
Type
protein
Length
155 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Induced myeloid leukemia cell differentiation protein mcl- 1
UniProt
Q07820
Ligands
Q4D
Pockets
1 · best druggability 0.60

Structure

x-ray diffraction · 1 distinct chain · 77% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInduced myeloid leukemia cell differentiation protein mcl- 1protein15577% helix, 0% strandQ07820

Ligands and binding sites

  • Q4D · (4s,7ar,9ar,10s,11e,18r)-6'-chloro-10-[2-(3,3-difluoroazetidin-1-yl)ethoxy]-N-(dimethylsulfamoyl)-18-hydroxy-15-methyl-16-oxo-3',4',7,7A,8,9,9A,10,13, 14,15,16,17,18-tetradecahydro-2'H,3H,5H-spiro[1,19-(ethanediylidene)cyclobuta[n][1,4]oxazepino[4,3-A][1, 8]diazacyclohexadecine-4,1'-naphthalene]-18-carboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11560.600.8318Q4D

Compared structures

  • 6UD2 · co-crystal structure of compound 1 bound to human Mcl-1 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.